Global Pharmatech, Inc.
GBLPOTCHealthcare● Active
$0.07
+$0.01(+7.69%)
Market Cap$29064825
P/E Ratio—
52W High$0.2
52W Low$0.05
Global Pharmatech, Inc. (GBLP) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GBLP · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2007-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.31M | $0.07M | $0.06M | $0.00M | $2.82M |
| Cost of Revenue | $0.28M | $0.02M | $0.03M | $0.00M | $1.89M |
| Gross Profit | $0.03M | $0.04M | $0.03M | $0.00M | $0.93M |
| Gross Margin %(computed) | 11.15% | 66.02% | 50.18% | — | 32.92% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.39M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $0.10M | $0.18M | $0.05M | $0.11M | $3.42M |
| Operating Income | ($0.07M) | ($0.14M) | ($0.02M) | ($0.11M) | ($2.49M) |
| Operating Margin %(computed) | -21.81% | -210.28% | -37.21% | — | -88.39% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.19M |
| Income Before Tax | ($0.07M) | ($0.14M) | ($0.02M) | ($0.11M) | ($2.50M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | ($0.05M) |
| Net Income | ($0.07M) | ($0.14M) | ($0.02M) | ($0.11M) | ($2.45M) |
| Net Margin %(computed) | -21.78% | -208.66% | -35.85% | — | -86.74% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.11 |
| Wtd Avg Shares | 405.21M | 395.21M | 282.85M | 276.35M | 23.25M |
| EBITDA | ($0.06M) | $0.03M | $0.21M | ($0.11M) | ($1.89M) |
| EBITDA Margin %(computed) | -19.27% | 44.84% | 354.35% | — | -67.19% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Global Pharmatech, Inc. data
About Global Pharmatech, Inc. (GBLP) Income Statement
Global Pharmatech, Inc. (GBLP) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, GBLP reported revenue of $0.00B, gross profit of $0.00B (gross margin 11.15%), and net income of ($0.00B) — a net profit margin of -21.78%.
Frequently asked questions
GBLP · 4 questionsGlobal Pharmatech, Inc. (GBLP) reported revenue of $0.00B for 2024, up 368.4% year-over-year.
GBLP revenueGBLP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09